Article

Serum kynurenine and beta-alanine levels are associated with Wnt pathway gene expression in leukocytes of patients with Parkinson's disease

2023-03-16

Abstract excerpt

<title>Abstract</title> <p><bold>Background: </bold>Parkinson's disease (PD) is the second most common neurodegenerative disease in the world. Despite its worldwide prevalence, there is currently no clear explanation of the mechanism of this disease. Moreover, the lack of reliable and accurate biomarkers makes the early detection of PD difficult. Therefore, we aimed to investigate serum beta-alanine and kynurenin...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 406dad9b-dfe1-5e3f-ae9c-f2188ee8a36d
DOI: 10.21203/rs.3.rs-2676291/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Serum kynurenine and beta-alanine levels are associated with Wnt pathway gene expression in leukocytes of patients with Parkinson's diseaseDOI 10.21203/rs.3.rs-2676291/v1Read

Dysregulated Wnt Signaling in Parkinson’s Disease: Correlation with Motor and Nonmotor Symptom SeveritySemantic proximity Read

Longitudinal Decline of Alanine Aminotransferase in Parkinson’s Disease and Its Association with Disease DurationSemantic proximity Read

The causative role and therapeutic potential of the kynurenine pathway in neurodegenerative diseaseSemantic proximity Read

MicroRNAs in Parkinson's diseaseSemantic proximity Read

Profile of microRNAs in the plasma of Parkinson’s disease patients and healthy controlsSemantic proximity Read

The kynurenine pathway and neurodegenerative diseaseSemantic proximity Read

miRNA expression is highly sensitive to a drug therapy in Parkinson's diseaseSemantic proximity Read

YKL-40 and Cellular Metabolic Profile in Parkinson’s DiseaseSemantic proximity Read

Kynurenine pathway in Parkinson's disease—An updateSemantic proximity Read

MicroRNA-326 Inhibits Apoptosis and Promotes Proliferation of Dopaminergic Neurons in Parkinson’s Disease Through Suppression of KLK7-Mediated MAPK Signaling PathwaySemantic proximity Read

Age‐ and disease‐specific changes of the kynurenine pathway in Parkinson’s and Alzheimer’s diseaseSemantic proximity Read

Nonsteroidal Anti-inflammatory Use and LRRK2 Parkinson's Disease Penetrance.Semantic proximity Read